Akela Pharma Inc. AKLPF

Healthcare Biotechnology

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

GREY:AKLPF - Post by User

Akela Pharma Inc.

<< Previous

Bullboard Posts

Next >>

Post by Consultor1on Apr 07, 2011 8:13am

471 Views

Post# 18397656

Insider

Someone has been reading our boards, not much but something.....

Akela Pharma Inc. (AKL)						As of April 6th, 2011
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Apr 06/11	Apr 06/11	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	.167 USD
Apr 04/11	Apr 04/11	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	.166 USD
Apr 04/11	Mar 27/11	Ingalls & Snyder, LLC	Direct Ownership	Warrants	55 - Expiration of warrants	-1,780,000
Mar 25/11	Mar 25/11	Boone, Horace Shepard	Direct Ownership	Common Shares	00 - Opening Balance-Initial SEDI Report
Jan 12/11	Dec 14/10	Rieder, Robert	Direct Ownership	Common Shares	10 - Acquisition in the public market	50,000	.130
Dec 29/10	Dec 23/10	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	.164 USD
Dec 22/10	Dec 22/10	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	1,500	.158 USD
Dec 20/10	Dec 20/10	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	.152 USD
Dec 20/10	Dec 20/10	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	500	.147 USD
Dec 20/10	Dec 20/10	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	1,000	.153 USD
- Amended Filing